The name “BRCA” is an abbreviation for “BReast CAncer gene.”. BRCA1 and BRCA2 are two different genes that have been found to impact a person’s chances of developing breast cancer. Every human has both the BRCA1 and BRCA2 genes.
People with a mutation in either the BRCA gene (also know as BRCA1/2) have risks of up to 87 percent for developing breast cancer and 39-63 percent for developing ovarian cancer by age 70.
At Positive Bioscience, our mission has always been to provide the highest-quality of testing to cancer patients to help secure the best possible outcome for each and every patient. With our mission in mind we partnered Myriad Genetics (USA), the founder of BRCA testing and a world leader in molecular diagnostics to bring their testing […]
Seems like cancers are running a marathon within themselves too…Latest data reveals, Pancreatic cancer spearheads breast cancer as the third leading cause of cancer death in US..! It is heartbreaking, but even today Pancreatic cancer sits at the backseat in terms of overcoming the common problems that hinder the treatment of pancreatic cancer. Lack of […]
In a treatment, how important is it to have the right diagnosis? What if the cancer that you are diagnosed with, has a risk associated with your family tree? With so much research going on in this space, how essential is it to know the detection and classification of the mutation variants? These are some […]
At Positive Bioscience we get a lot of queries from patients: from testing (our specialty) to treatment to genetic counseling. Recently we have an increasing number of patient queries asking a dreaded question: is this my fault? What could I have done differently? Unfortunately, in most cases, the answer is not easy. There are risk […]
Cancer Biomarkers vs Cancer Screening Test A common question Positive Bioscience (India) is asked “what is the difference between cancer biomarkers and cancer screening?” Here’s what you need to know. Cancer Biomarkers: Cancer biomarker testing is exclusively for cancer patients. Cancer biomarkers help to decide the course of treatment and are especially used for newly […]